The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
ISSN-L : 0040-8727
Profile of Blood Coagulation and Fibrinolysis in Chronic Myeloproliferative Disorders
HOYU TAKAHASHIAKIRA HATTORIAKIRA SHIBATA
著者情報
ジャーナル フリー

1982 年 138 巻 1 号 p. 71-80

詳細
抄録

TAKAHASHI, H., HATTORI, A, and SHIBATA, A. Profile of Blood Coagulation and Fibrinolysis in Chronic Myeloproliferative Disorders. Tohoku J. exp. Med., 1982, 138 (1), 71-80 Blood coagulation and fibrinolysis were studied in 65 patients with chronic myeloproliferative disorders (MPD). They consisted of 28 patients with chronic granulocytic leukemia (CGL) in chronic phase, 7 with CGL in blast crisis, 9 with polycythemia vera (PV), 13 with primary thrombocythemia (PTh) and 8 with primary myelofibrosis (MF). Hemorrhagic and thrombotic complications were observed in 19 and 8 patients, respectively. Activated partial thromboplastin time and prothrombin time were prolonged in many patients. Low factor II levels were observed in some CGL patients. Factor V was decreased in CGL patients in chronic phase and in PV patients. Fibrinogen was either normal or increased in most patients, but an elevation of fibrin/fibrinogen degradation products (FDP) was found in some patients. The VIIIR: Ag/VIII:C ratio was increased in CGL patients in blast crisis, in PV patients and in PTh patients. Antithrombin III and plasminogen were below normal in some patients. Most patients showed a decrease in α2-plasmin inhibitor. These findings suggest that blood coagulation and fibrinolysis are involved in the pathogenesis of the thrombotic and hemorrhagic complications in these patients. Chronic low-grade intravascular coagulation might be present in some patients with MPD.

著者関連情報
© Tohoku University Medical Press
前の記事 次の記事
feedback
Top